HOOKIPA Pharma Files Definitive Proxy Statement
Ticker: HOOK · Form: DEFA14A · Filed: Jun 4, 2025 · CIK: 1760542
| Field | Detail |
|---|---|
| Company | Hookipa Pharma Inc. (HOOK) |
| Form Type | DEFA14A |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-meeting
TL;DR
HOOKIPA Pharma filed its proxy statement, get ready for shareholder votes.
AI Summary
HOOKIPA Pharma Inc. filed a Definitive Proxy Statement (DEFA14A) on June 4, 2025, related to its upcoming shareholder meeting. The filing indicates that this is a solicitation of proxies under Section 14(a) of the Securities Exchange Act of 1934, and it is not a preliminary proxy statement. The company is based in New York and incorporated in Delaware.
Why It Matters
This filing is a standard regulatory requirement for public companies to inform shareholders about matters to be voted on at an upcoming meeting, ensuring transparency and shareholder participation.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) and does not contain new financial information or strategic decisions that would inherently increase risk.
Key Players & Entities
- HOOKIPA Pharma Inc. (company) — Registrant
- 0001104659-25-056400 (filing_id) — Accession Number
- 20250604 (date) — Filing Date
- New York (location) — Business Address City
- DE (state) — State of Incorporation
FAQ
What type of SEC filing is this?
This is a Definitive Proxy Statement (DEFA14A) filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Who is the filing company?
The filing company is HOOKIPA Pharma Inc.
When was this filing made?
The filing was made on June 4, 2025.
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a definitive proxy statement used to solicit votes from shareholders for an upcoming company meeting.
Where is HOOKIPA Pharma Inc. located?
HOOKIPA Pharma Inc.'s business address is in New York, NY.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 4, 2025 regarding HOOKIPA Pharma Inc. (HOOK).